Related Experiment Video
Updated: Jun 8, 2026
08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Antibodies in cancer immunotherapy
Lavakumar Karyampudi1, Keith L Knutson
1Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Cancer Biomarkers : Section a of Disease Markers
|October 13, 2010
Summary
Monoclonal antibodies are effective cancer therapeutics, with eight FDA-approved treatments and more in clinical trials. This review explores their mechanisms, strategies for enhanced effectiveness, and combination therapies for improved cancer treatment outcomes.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Monoclonal antibodies represent a significant advancement in cancer therapy.
- Eight monoclonal antibodies are currently FDA-approved for treating various cancers.
- Numerous other antibodies are in late-stage clinical trials.
Purpose of the Study:
- To review current monoclonal antibody therapies for cancer.
- To discuss their mechanisms of action.
- To explore strategies for enhancing antibody effectiveness and combination therapies.
Main Methods:
- Review of existing literature on monoclonal antibody cancer therapeutics.
- Analysis of approved antibodies and those in clinical trials.
- Discussion of therapeutic strategies and combination approaches.
Main Results:
- Monoclonal antibodies demonstrate efficacy across diverse cancer types.
- Antibodies target tumor cells directly or indirectly to reduce tumor burden.
- Combination therapies with chemotherapeutic agents show promise.
Conclusions:
- Monoclonal antibody therapy is a rapidly evolving field with substantial public health impact.
- Ongoing research focuses on improving antibody efficacy and expanding therapeutic applications.
- Combination strategies are crucial for maximizing treatment benefits.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...